AzTrials
AzTrials

Chronic Low-back PainNCT05268822

Movement Control Exercises With and Without Specific Breathing Techniques for the Treatment of Chronic Low Back Pain

A study testing Home exercise in people with Chronic Low-back Pain, run by Kuopio University Hospital at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Chronic low back pain (CLBP) is a leading disability globally. Exercise therapies are one of the most commonly prescribed treatment options for CLBP. Specific breathing techniques have been shown to enhance brain-based pain modulation and autonomic nervous system balance; these changes have been shown to improve… Read more about this study

Who is it for?
Ages 18 to 68 yearsHealthy volunteers can take part
Conditions the study is for
Chronic Low-back Pain
What is being tested?
Home exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFinland
Study dates
8 Feb 2022to 14 Nov 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 68 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 18-68-years-old
  • Low back pain lasting more than 3 months (pain sensation more than 3 days per week)
  • A numerical pain scale of more than 3
  • ≥ 2/6 positive low back movement control tests (as described by Luomajoki et al.)
  • Roland-Morris Disability Questionnaire score of five or greater
  • Who are physically able to perform movement control tests and provide written informed consent.

Who cannot join

  • Any history of malignant cancer
  • Neurological disease affecting the central nervous system (MS, dementia)
  • Rheumatic disease (fibromyalgia, ankylosing spondylitis/rheumatoid arthritis)
  • Chronic obstructive pulmonary disease,
  • Spinal surgery in the last 12 months
  • A cardiac pacemaker
  • Signs and symptoms of nerve root pathology during the clinic visits.
  • Women who become pregnant during the data collection will also be excluded from the study.

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Private Clinic of principal investigator

    Helsinki, Uusimaa, 00100

Other trials in Finland

About this study

Official title: Movement Control Exercises With and Without Specific Breathing Techniques for the Treatment of Chronic Low Back Pain: an Open-label Feasibility Study With 2-month

Chronic low back pain (CLBP) is a leading disability globally. Exercise therapies are one of the most commonly prescribed treatment options for CLBP. Specific breathing techniques have been shown to enhance brain-based pain modulation and autonomic nervous system balance; these changes have been shown to improve clinical effectiveness in terms of pain management and psychological factors compared to general exercise. However, no previous studies have added a specific breathing technique protocol to an evidence-based exercise program for CLBP.

Being tested
Home exercise

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home exerciseOther

    Movement control exercise with or without specific breathing techniques

Study groups in NCT05268822
Study groupRoleWhat they receive
Movement control exercise with specific breathing techniquesActive comparatorMovement control exercise with specific breathing techniques (experimental group)
Receives: Other: Home exercise
Movement control exercise without specific breathing techniquesActive comparatorMovement control exercise without specific breathing techniques (control group)
Receives: Other: Home exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The numerical pain rating scale (NRPS)

    Eleven-point numerical pain scale. Scale from 0 (no pain) to 10 (worst imaginable)

    Measured: Change from Baseline The numerical pain rating scale at 2 months

  2. Well-Being in Pain Questionnaire

    Self-developed questionnaire to screen the effects of pain on a person's biopsychosocial well-being. Scale from 0 (no subjective well-being in pain) to 60 (maximum subjective well-being in pain)

    Measured: Change from Baseline Well-Being in Pain Questionnaire at 2 months

  3. The Roland Morris Disability Questionnaire (RMDQ)

    Questionnaire measuring disability in chronic low back pain populations. Scale from 0 (no disability) to 24 (maximum low back pain related disability)

    Measured: Change from Baseline The Roland Morris Disability Questionnaire at 2 months

  4. Central Sensitization Inventory (CSI)

    Screening of central sensitization phenomenon. Scale from 0 (no central sensitization) to 100 (worst imaginable central sensitization)

    Measured: Change from Baseline Central Sensitization Inventory at two months

  5. The 5-level EQ-5D version of the EuroQol

    Health status. Scale from 0 (dead) to 1 (full health)

    Measured: Change from Baseline The 5-level EQ-5D version of the EuroQol at 2 months

  6. The Generalised Anxiety Disorder Assessment (GAD-7)

    Measure of generalised anxiety disorder related symptoms. Scale from 0 (the most minimal anxiety) to 21 (the most severe anxiety)

    Measured: Change from Baseline The Generalised Anxiety Disorder Assessment at two months

  7. The Tampa Scale of Kinesiophobia (TSK)

    Assessment of subjective kinesiophobia (fear of movement). Scale from 17 (the minimal kinesophobia) to 68 (the most maximum kinesiophobia).

    Measured: Change from Baseline The Tampa scale of Kinesiophobia at two months

  8. The Pain Catastrophizing Scale (PCS)

    Assessment of catastrophizing (tendency to magnify the threat value of a pain stimulus) related to pain. Scale from 0 (no catastrophizing thoughts) to 52 (maximum catastrophizing thoughts)

    Measured: Change from Baseline he Pain Catastrophizing Scale at two months

  9. The Pain and Sleep Questionnaire Three-Item Index (PSQ-3)

    Effect of pain on sleep. Scale from 0 (pain have no any effect on sleep) to 30 (pain have maximum effect on sleep)

    Measured: Change from Baseline The Pain and Sleep Questionnaire Three-Item Index at two months

  10. The Pain Self-Efficacy Questionnaire (PSEQ)

    assess the self-efficacy of people in pain have in daily activities. The scale is from 0 points (not at all confident) to 6 points (completely confident).

    Measured: Change from Baseline The Pain and Sleep Questionnaire Three-Item Index at two months

Secondary outcomes (3)
  1. Feasibility of intervention protocol, recruitment and enrollment

    To assess the feasibility of the intervention protocol and subject recruitment and enrollment.

    Measured: Through study completion, an average of 2 mothns

  2. Responsiveness

    To quantify the changes in and determine the responsiveness of the outcome measures, in order to calculate the sample size for a randomized controlled trial (RCT) based on the chosen primary outcome measure(s).

    Measured: Through study completion, an average of 2 months

  3. Quantifying

    To quantify the changes in self-adherence levels to home exercise and monitor possible pain medication usage, and side effects, adverse events and injuries during exercise.

    Measured: Through study completion, an average of 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2022
  2. Study start8 Feb 2022
  3. Primary completion14 Nov 2022
  4. Study completion14 Nov 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
An open-label feasibility study with study subject allocated to movement control exercise with specific breathing techniques (experimental group) or movement control exercise without specific breathing techniques (control group)
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05268822
Sponsor's protocol ID
KuopioUH_2022
Status last verified
Mar 2023
First submitted
8 Feb 2022
Last updated
9 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Mikkonen J, Luomajoki H, Airaksinen O, Goubert L, Pratscher S, Leinonen V. Identical movement control exercises with and without synchronized breathing for chronic non-specific low back pain:A randomized pilot trial. J Back Musculoskelet Rehabil. 2024;37(6):1561-1571. doi: 10.3233/BMR-230413.

    PubMed 39031339
  • Mikkonen J, Luomajoki H, Airaksinen O, Goubert L, Leinonen V. Protocol of identical exercise programs with and without specific breathing techniques for the treatment of chronic non-specific low back pain: randomized feasibility trial with two-month follow-up. BMC Musculoskelet Disord. 2023 May 5;24(1):354. doi: 10.1186/s12891-023-06434-6.

    PubMed 37147638

Questions about this trial

What is this clinical trial studying?

A study testing Home exercise in people with Chronic Low-back Pain, run by Kuopio University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The numerical pain rating scale (NRPS) (time frame: Change from Baseline The numerical pain rating scale at 2 months). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05268822, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in